Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

[Marketwired] – Horizon Pharma, Inc. today announced that on March 27, 2014 the Compensation Committee of its Board of Directors approved the grant of inducement stock options to purchase an aggregate of 96,750 shares … more

View todays social media effects on HZNP

View the latest stocks trending across Twitter. Click to view dashboard

See who Horizon is hiring next, click here to view

Share this post